Monthly Archives: February 2012

31-01-2012 15:24 MDA Vice President of Research Sanjay Bidichandani explains the promising research being done in neuromuscular disease research using adult stem cells. Here is the original post: Stem Cell Therapy in Neuromuscular Disease Research - Video … Continue reading →

16-03-2010 15:02 3/16/2010-Shares of Icagen (NASDAQ:ICGN) are trading 40.5% higher to $0.76 Tuesday after the company reported positive results in its Phase IIa epilepsy study of ICA-105665, its novel orally available small molecule KCNQ potassium channel agonist. "The trial met its endpoints," noted Jacqueline A. French, MD, Professor and Director of the Clinical Trials Consortium at the NYU Comprehensive Epilepsy Center, "While more studies will be required to establish the potential utility of this compound in the treatment of epilepsy, the results of this photosensitive epilepsy model provide important proof-of-concept data for this novel drug candidate." Read the original here: News Update: Icagen Soars on Positive Study Results for ICA-105665 Epilepsy Treatment Compound - Video … Continue reading →

16-01-2012 07:54 See the original post: Autism Help - Thoughts on Activities For Your child - The Son-Rise Program - Video … Continue reading →

By Peter Korn The Portland Tribune, Feb 3, 2012 ADVERTISEMENTS A new procedure to help people in the crucial first hours after they have suffered strokes may soon be the standard of care, according to an Oregon Health & Science researcher who contributed to a study released Friday. Traditionally, victims of strokes – which involves clots blocking the flow of blood to the brain – are treated with a corkscrew-like device that is twisted into the clot and gently pulled out. The new procedure opens the blocked artery by inserting into the brain a small mesh stent made of platinum and titanium. The stent expands the interior walls of the artery and allows blood to get to the patient’s brain. The clot is captured by the sent and after a few minutes the stent and clot are removed together. A study of the new procedure was presented this morning at a medical conference in New Orleans. The study involved more than 140 stroke patients at 18 medical centers throughout the U.S., 35 of whom were treated at OHSU. The new stent procedure appeared more effective than a traditional device, according to the study. More than half the patients treated with … Continue reading →

FRIDAY, Feb. 3 (HealthDay News) -- While a clot-busting medication can often help stop a stroke in its tracks if it's given promptly, a new study finds that a high number of stroke victims continue to fail to get to the emergency room quickly enough to get the drug. An analysis of about 115,000 patients who had strokes between 2005 and 2010 found that almost 44 percent didn't get to the hospital until more than 4.5 hours after the time they were known to first show symptoms. That's a sign of trouble: it's actually up from 39 percent in 2005. Meanwhile, the percentage who got to the hospital within two hours fell from 40 percent in 2005 to 35 percent in 2010, another sign that more patients may be in danger from not getting prompt care. Also, many patients chose to get themselves to the hospital instead of calling an ambulance, "boosting the risk that they won't get there in time to be able to take a clot-busting drug," said study co-author Dr. Mary George, a medical officer with the division for heart disease and stroke prevention at the U.S. Centers for Disease Control and Prevention. The main message of … Continue reading →

17-10-2011 14:15 This video, is a testimonial of a patient from Colorado, USA that went to Progencell, for a Stem cell treatment for her neurologic problem affecting her eyesight and hearing loss. Talks about her experience, her trip, the procedure, the outcome and some suggestions. Language english with Spanish subtitles, 2:34 min duration Read the original: Eyesight and Hearing loss - Stem Cell therapy (English) - Video … Continue reading →